LUX Infusion Strengthens Northeast Presence with Acquisition of Two Ambulatory Infusion Centers

LUX Infusion, a clinician-led infusion services company, announced on September 11, 2026, the acquisition of two ambulatory infusion centers (AICs): South Jersey Pediatric and Adult Infusion Center located in Cherry Hill, New Jersey, and Northeast Infusion Therapy in Latham, New York. The deal, valued at an undisclosed amount, marks a strategic expansion of LUX Infusion's footprint in the northeastern United States, enhancing its commitment to delivering patient-centered infusion care in accessible and clinically supervised environments.

The acquisition of South Jersey Pediatric and Adult Infusion Center and Northeast Infusion Therapy underscores LUX Infusion's strategy to broaden its service offerings and improve access to high-quality infusion therapies. Both centers have established themselves as vital components of their local healthcare ecosystems, focusing on patient comfort and collaboration with referring physicians. South Jersey Pediatric and Adult Infusion Center caters to both pediatric and adult patients, providing a comfortable outpatient setting for medically prescribed infusion services. Meanwhile, Northeast Infusion Therapy specializes in treating adults with chronic diseases, emphasizing a supportive and private environment for patients.

LUX Infusion's expansion aligns with broader trends in the healthcare sector, particularly the increasing demand for outpatient infusion services. As healthcare providers seek to enhance patient experiences and streamline care delivery, the AIC model has gained traction. This model allows for more personalized care, reducing the need for hospital visits while ensuring that patients receive necessary treatments in a controlled and comfortable setting. By integrating these two centers into its network, LUX Infusion is positioned to capitalize on this growing demand, enhancing its ability to deliver coordinated care across a wider geographic area.

The acquisition also reflects LUX Infusion's ongoing commitment to clinician-led care, which prioritizes clinical expertise and patient-centered approaches. The company, backed by Frazier Healthcare Partners, aims to create an omnichannel network that facilitates seamless access to infusion therapies while maintaining high standards of care. By welcoming South Jersey Pediatric and Adult Infusion Center and Northeast Infusion Therapy into its fold, LUX Infusion is set to provide continuity for patients and healthcare providers alike, ensuring that care transitions are smooth and efficient.

Looking ahead, the integration of these centers is expected to strengthen LUX Infusion's market position in the infusion services sector, particularly in the northeastern United States. As the demand for outpatient care continues to rise, LUX Infusion's expansion strategy may serve as a model for other healthcare providers seeking to enhance their service offerings and improve patient access to essential therapies. The successful execution of this acquisition could pave the way for further growth opportunities within the rapidly evolving landscape of outpatient healthcare services.